pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
aulos-bioscience PRESS RELEASE ARCHIVE
Nov 10, 2022
Aulos Bioscience Presents Initial Data From First-in-Human Phase 1/2 Clinical Trial of Computationally Designed Antibody AU-007 at 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 5, 2021
Aulos Bioscience to Present New Preclinical Data on Computationally Evolved IL-2 Human Antibody AU-007 at 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Jun 14, 2021
Jim Vasselli, M.D., Joins Aulos Bioscience as Chief Medical Officer
May 17, 2021
Aulos Bioscience Appoints Leo Redmond as Chief Financial Officer
Mar 30, 2021
Mace Rothenberg, M.D., Joins Aulos Bioscience Board of Directors USA - English USA - English USA - English
Mar 15, 2021
Aulos Bioscience Appoints Aron Knickerbocker as CEO
Jan 9, 2021
ATP und Biolojic Design gründen Aulos Bioscience zur Entwicklung eines hochdifferenzierten IL-2-Antikörper-Ansatzes gegen Krebs Israel - Deutsch USA - English Israel - English USA - español USA - Français
Jan 8, 2021
ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer USA - English Israel - English USA - español USA - Deutsch USA - Français
Jan 8, 2021
ATP y Biolojic Design lanzan Aulos Bioscience Israel - español USA - English Israel - English USA - Deutsch USA - Français
Jan 8, 2021
ATP et Biolojic Design lancent Aulos Bioscience pour développer une approche hautement différenciée des anticorps IL-2 dans la lutte contre le cancer USA - Français USA - English Israel - English USA - español USA - Deutsch
Jan 8, 2021
ATP y Biolojic Design lanzan Aulos Bioscience
